in vitro News and Research

RSS

CellPort Software joins the Tetra Partner Network to help customers accelerate cell development and manufacturing

TetraScience, the R&D Data Cloud company, announced today that CellPort Software, a SaaS company that digitizes workflows for cell development and manufacturing, has joined the Tetra Partner Network to accelerate delivery of cell-based therapeutics.

From TetraScience, Inc. 15 Dec 2021

Providing quick & efficient CRO services with Sino Biological

In this interview, News-Medical talks to Dr. Lin Yutao, head of project management at Sino Biological, about the work she does and how Sino provides quick and efficient recombinant CRO services.

From Sino Biological Inc. 15 Dec 2021

New stroke treatment imitates the survival strategy of C. elegans

Each year, some 200,000 people in Germany and 1 million people in Europe suffer a stroke. This happens when blood clots obstruct major vessels and there is no longer sufficient supply of blood to the brain.

14 Dec 2021

Evaluating the virucidal activity of blue LED light against SARS-CoV-2 infection

A new study provides some possible explanations to the mechanisms by which antiviral activity is exerted by blue LED light and indicated that the alteration of the SARS-CoV-2 spike protein requires the presence of photosensitizers.

13 Dec 2021

Researchers develop a universal SARS-CoV-2 neutralizing antibody

A new study has been published in Frontiers in Immunology, where scientists developed a universal SARS-CoV-2 neutralizing antibody, MG1141A.

13 Dec 2021

Genetic-code expansion technique to potentially create next-generation vaccine candidate

A new experiment devised a novel method to manipulate virulent viruses in conventional laboratories and validated the prophylactic effect of this method in two mouse models.

13 Dec 2021

Effect of mutations on SARS-CoV-2 E protein interactions with cell junctions

In a recent study, ten human PDZ-containing proteins showed significant interactions with the SARS-CoV-2 E protein in a PBM-dependent manner.

12 Dec 2021

Even if SARS-CoV-2 Omicron evades antibodies, immunity still exists

Researchers determined antibody-mediated neutralization efficacy against the authentic SARS-CoV-2 Omicron variant.

12 Dec 2021

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Published today, one of the earliest, peer-reviewed studies looking into the Omicron variant of COVID-19 suggests that people previously infected with COVID, and those vaccinated, will have some, "stronger than basic" defense against this new strain of concern.

12 Dec 2021

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Researchers have screened several compounds that could show the ability to inhibit SARS-CoV-2.

10 Dec 2021

Characterization of SARS-CoV-2 spike protein mutation with no associated increase in epidemiological fitness

Researchers from the Centro de Investigaciones Biológicas Margarita Salas have been investigating one of the mutations that typically appear in the Delta variant.

9 Dec 2021

Study reveals the role of intracellular receptor PQBP1 in response to Tau protein

Just as a home security system can alert a homeowner to the presence of an intruder, a protein called polyglutamine binding protein-1 (PQBP1) found in brain cells can alert the body to the presence of "intruding" viruses like human immunodeficiency virus (HIV).

9 Dec 2021

in vitro News and Research

CellPort Software joins the Tetra Partner Network to help customers accelerate cell development and manufacturing

Providing quick & efficient CRO services with Sino Biological

New stroke treatment imitates the survival strategy of C. elegans

Evaluating the virucidal activity of blue LED light against SARS-CoV-2 infection

Researchers develop a universal SARS-CoV-2 neutralizing antibody

Genetic-code expansion technique to potentially create next-generation vaccine candidate

Effect of mutations on SARS-CoV-2 E protein interactions with cell junctions

Even if SARS-CoV-2 Omicron evades antibodies, immunity still exists

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Characterization of SARS-CoV-2 spike protein mutation with no associated increase in epidemiological fitness

Study reveals the role of intracellular receptor PQBP1 in response to Tau protein

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Potential association between senescence and aging in COVID-19

High quality products for cultured meat research

Study identifies ORF8 protein as a key COVID-19 causing factor

Epigenetic clocks have potential as biomarkers of COVID-19 vaccine responses

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

Research offers pathway for manufacturing cell cultured meat and breeding enhanced livestock

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News